Stock Watch, 19 October 2009

The Share Centre’s top 5 buys from the last 7 days:

1. Bglobal – Share of the week.
2. Phytopharm – Positive move after disease treatment for Parkinsons shows early success.
3. Lloyds Banking Group sful trials and investors follow. – Still buyers moving in despite rights issue possibility.
4. Tesco – Investors looking for stability moving in.
5. Oxford Biomedica – Jumps on succes
 

The Share Centre’s top 5 shares to follow:

1. National Grid Lower Risk – Defensive nature of business will be attractive if market rally peters out.
2. GlaxoSmithKline Lower Risk – Pharmaceutical giant looks worth tucking away.
3. Experian Medium Risk – Credit data company thriving in current market conditions.
4. Man Group Medium Risk – Financial group worth a closer look.
5. Clarkson Higher Risk – Shipping contractor with good global exposure.
 

Ratio of buys to sells = 60:40%



Top 5 most searched for companies on www.share.com

1. Standard Life
3. Debenhams
3. Legal and General
4. Friends Provident
5. DSG International



The Share Centre’s Share of the Week 19/10/09

Company: Experian    Share price: 570.00p    Sector: Support Services
Recommendation:    Buy
Risk category:    Medium
Investment class:    Growth
Opinion:
The company has so far largely shrugged off the recession as a result of an expansion of the range of industries that the group services, Experian has already moved from its original focus on financial services to a wider expertise in automotive, telecoms, debt collection advice and the public sector. The company is also looking for opportunities to extend its geographic reach and to make bolt on acquisitions where appropriate.


Longer term potential remains as indicated by the shares resilience, any sign of a return to normality in the credit markets and Experian will be well positioned to take advantage. One to steadily tuck away for the future.



This data is provided by Graham Spooner, investment adviser at The Share Centre. This is not intended to constitute an offer or agreement to buy or sell investments.

Moneyextra.com recommends you take independent financial advice before acting on any article

2009-10-21 15:07:45 © Moneyextra.com